Dynamic, large-scale profiling of transcription factor activity from live cells in 3d culture

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Weiss, Michael S ^a   Bernabé, Beatriz Peñalver ^a   Bellis, Abigail D ^a   Broadbelt, Linda J ^a   Jeruss, Jacqueline S ^b   Shea, Lonnie D ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ESTRADIOL; LUCIFERASE; MATRIGEL; TRANSCRIPTION FACTOR; ACTIVIN; COLLAGEN; ESTROGEN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LAMININ; PROTEOGLYCAN;

ARTICLE; CELL CULTURE; CELL LINE; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; QUANTITATIVE ANALYSIS; REPORTER GENE; SIGNAL TRANSDUCTION; CULTURE TECHNIQUE; DRUG COMBINATION; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HUMAN; INSTRUMENTATION; KINETICS; LUMINESCENCE; METABOLISM; METHODOLOGY; TUMOR CELL LINE;

ACTIVINS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; ESTRADIOL; ESTROGENS; GREEN FLUORESCENT PROTEINS; HUMANS; KINETICS; LAMININ; LUCIFERASES; LUMINESCENT MEASUREMENTS; PROTEOGLYCANS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 78649512741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014026     Document Type: Article

References (67)

1. Courtois G, Gilmore TD (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25: 6831-6843.
2. Jordan JD, Landau EM, Iyengar R (2000) Signaling networks: the origins of cellular multitasking. Cell 103: 193-200.
3. Miller-Jensen K, Janes KA, Brugge JS, Lauffenburger DA (2007) Common effector processing mediates cell-specific responses to stimuli. Nature 448: 604-608.
4. Reuter JA, Ortiz-Urda S, Kretz M, Garcia J, Scholl FA, et al. (2009) Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. Cancer Cell 15: 477-488.
5. Dreesen O, Brivanlou AH (2007) Signaling pathways in cancer and embryonic stem cells. Stem Cell Reviews 3: 7-17.
6. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
7. Moustakas A, Heldin C-H (2007) Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Science 98: 1512-1520.
8. King KR, Wang S, Irimia D, Jayaraman A, Toner M, et al. (2007) A highthroughput microfluidic real-time gene expression living cell array. Lab on a chip 7: 77-85.
9. Huebsch N, Mooney DJ (2009) Inspiration and application in the evolution of biomaterials. Nature 462: 426-432.
10. Kenny P, Lee G, Myers C, Neve R, Semeiks J, et al. (2007) The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Molecular oncology 1: 84-96.
11. Weaver VM, Lelièvre S, Lakins JN, Chrenek MA, Jones JCR, et al. (2002) beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2: 205-216.
12. Zhang Y, Zhao H, Asztalos S, Chisamore M, Sitabkhan Y, et al. (2009) Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix. Mol Cancer Res 7: 498-510.
13. Pannier AK, Ariazi EA, Bellis AD, Bengali Z, Jordan VC, et al. (2007) Bioluminescence imaging for assessment and normalization in transfected cell arrays. Biotechnol Bioeng 98: 486-497.
14. Kleinman HK, Martin GR (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386.
15. Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC (1992) An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Mol Cell Endocrinol 90: 77-86.
16. Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, et al. (2008) The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene 27: 366-377.
17. Lewis-Wambi JS, Jordan VC (2009) Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Research 11: 206-217.
18. Harris CC (1996) p53 tumor suppressor gene: from the basic research laboratory to the clinic-an abridged historical perspective. Carcinogenesis 17: 1187-1198.
19. Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, et al. (2008) p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS ONE 3: e3707.
20. Ikeda K, Inoue S (2004) Estrogen receptors and their downstream targets in cancer. Arch Histol Cytol 67: 435-442.
21. Molinari AM, Bontempo P, Schiavone EM, Tortora V, Verdicchio MA, et al. (2000) Estradiol induces functional inactivation of p53 by intracellular redistribution. Cancer Research 60: 2594-2597.
22. Philips A, Chalbos D, Rochefort H (1993) Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem 268: 14103-14108.
23. Woodward TL, Lu H, Haslam SZ (2000) Laminin inhibits estrogen action in human breast cancer cells. Endocrinology 141: 2814-2821.
24. Darnell JE (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2: 740-749.
25. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
26. Dedieu S, Lefebvre P (2006) Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cellular Signalling 18: 889-898.
27. Romanov S, Medvedev A, Gambarian M, Poltoratskaya N, Moeser M, et al. (2008) Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors. Nat Methods 5: 253-260.
28. Sabbah M, Courilleau D, Mester J, Redeuilh G (1999) Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96: 11217-11222.
29. de la Iglesia N, Konopka G, Lim K-L, Nutt CL, Bromberg JF, et al. (2008) Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 28: 5870-5878.
30. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
31. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254.
32. Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ (2003) ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 163: 583-595.
33. Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK (2005) Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Cancer Res 65: 7968-7975.
34. Liu J, Li C, Ahlborn TE, Spence MJ, Meng L, et al. (1999) The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. Cell Growth Differ 10: 677-683.
35. Cheng C, Li LM (2008) Systematic identification of cell cycle regulated transcription factors from microarray time series data. BMC Genomics 9: 116.
36. Souchelnytskyi S (2002) Proteomics in studies of signal transduction in epithelial cells. Journal of mammary gland biology and neoplasia 7: 359-371.
37. Benitah SA, Valerón PF, van Aelst L, Marshall CJ, Lacal JC (2004) Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta 1705: 121-132.
38. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275: 1930-1934.
39. Bhalla US, Iyengar R (1999) Emergent properties of networks of biological signaling pathways. Science 283: 381-387.
40. Kholodenko BN (2006) Cell-signalling dynamics in time and space. Nature Reviews Molecular Cell Biology 7: 165-176.
41. Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The IkappaB-NFkappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245.
42. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
43. Murphy LO, Smith S, Chen R-H, Fingar DC, Blenis J (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4: 556-564.
44. Varga CM, Hong K, Lauffenburger DA (2001) Quantitative analysis of synthetic gene delivery vector design properties. Mol Ther 4: 438-446.
45. Deniaud E, Baguet J, Chalard R, Blanquier B, Brinza L, et al. (2009)Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition. PLoS ONE 4: e7035.
46. Jauliac S, López-Rodriguez C, Shaw LM, Brown LF, Rao A, et al. (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4: 540-544.
47. Cocolakis E, Lemay S, Ali S, Lebrun JJ (2001) The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem 276: 18430-18436.
48. Ho J, de Guise C, Kim C, Lemay S, Wang X-F, et al. (2004) Activin induces hepatocyte cell growth arrest through induction of the cyclin-dependent kinase inhibitor p15INK4B and Sp1. Cellular Signalling 16: 693-701.
49. Yun C-H, Choi S-C, Park E, Kim S-J, Chung A-S, et al. (2007) Negative regulation of Activin/Nodal signaling by SRF during Xenopus gastrulation. Development 134: 769-777.
50. Debnath J, Brugge JS (2005) Modelling glandular epithelial cancers in threedimensional cultures. Nat Rev Cancer 5: 675-688.
51. Dimri M, Naramura M, Duan L, Chen J, Ortega-Cava C, et al. (2007) Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer Research 67: 4164-4172.
52. Petersen OW, Rønnov-Jessen L, Howlett AR, Bissell MJ (1992) Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci US A 89: 9064-9068.
53. Streuli CH, Gilmore AP (1999) Adhesion-mediated signaling in the regulation of mammary epithelial cell survival. Journal of mammary gland biology and neoplasia 4: 183-191.
54. Peyton SR, Kim PD, Ghajar CM, Seliktar D, Putnam AJ (2008) The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials 29: 2597-2607.
55. Chang JH, Pratt JC, Sawasdikosol S, Kapeller R, Burakoff SJ (1998) The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Molecular and Cellular Biology 18: 4986-4993.
56. Denhardt DT (1996) Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 318(Pt 3): 729-747.
57. Duan R, Xie W, Li X, McDougal A, Safe S (2002) Estrogen regulation of c-fos ene expression through phosphatidylinositol-3-kinase-dependent activation of erum response factor in MCF-7 breast cancer cells. Biochemical and iophysical Research Communications 294: 384-394.
58. Coleman ML, Marshall CJ, Olson MF (2004) RAS and RHO GTPases in G1- hase cell-cycle regulation. Nature Reviews Molecular Cell Biology 5: 355-366.
59. Ignowski JM, Schaffer DV (2004) Kinetic analysis and modeling of firefly uciferase as a quantitative reporter gene in live mammalian cells. Biotechnol ioeng 86: 827-834.
60. http://www.panomics.com/index.php?id=product_44.
61. Wieland JA, Houchin-Ray TL, Shea LD (2007) Non-viral vector delivery from EG-hyaluronic acid hydrogels. Journal of controlled release: official journal of he Controlled Release Society 120: 233-241.
62. R Team (2008) R: A language and environment for statistical computing, ienna, Austria.
63. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical nd powerful approach to multiple testing. Journal of the Royal Statistical ociety: Series B (Methodological) 57: 289-300.
64. Smyth GK (2005) Limma: linear models for microarray data; Gentleman R, aey V, Dudoit S, Irizarry R, Huber W, eds. New York, New York: Springer. p 397-420.
65. Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS (2002) Truncated product ethod for combining P-values. Genet Epidemiol 22: 170-185.
66. Lonnstedt I, Speed T (2002) Replicated microarray data. Statistical Sinica 12: 1-46.
67. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology 3: Article3.